Overview
To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
Description
- Objectives
-
- To estimate the prevalence and severity of adverse and functional outcomes in survivors of benign and malignant paranasal sinus, nasopharynx and skull base tumors.
- To estimate the prevalence of health promotion behaviors during skull base tumor survivorship
- To identify possible mediators or predictors of survivorship outcomes and health behaviors in survivors of skull base tumors.
- To develop a database of demographic, clinicopathologic, recurrence, survival, functional and patient reported outcomes (PROS) for patients with benign and malignant paranasal sinus, nasopharyngeal and skull base tumors.
- To assess the utility and limitations of PROs in evaluating functional impairments and symptom burden in skull base patients.
Eligibility
Inclusion criteria:
- Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
- Age ≥ 18 years
- Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
- Ability to understand and willingness to sign written informed consent
Exclusion criteria:
- History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
- Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
- Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.